Deutsch English Français

Contact

EP2614045

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2614045

EP2614045 - METHOD FOR PRODUCING CRYSTALLINE 5-AMINOSALICYLIC ACID [Right-click to bookmark this link]
Status	Patent revoked Status updated on 15.04.2019 Database last updated on 18.11.2024
Former	The patent has been granted Status updated on 21.12.2016
Most recent event Tooltip	17.04.2020	Lapse of the patent in a contracting state New state(s): CY	published on 20.05.2020 [2020/21]
Applicant(s)	For all designated states PharmaZell GmbH Rosenheimer Str. 43 83064 Raubling / DE
	[2013/29]
Inventor(s)	01 / GAAB, Stefan Ritter-von-Lex-Weg 4 83022 Rosenheim / DE
	02 / HARTUNG, Alexander Hofstatt 21 83512 Wasserburg / DE
	03 / AIGNER, Arno Fuchsbergstraße 12 83104 Tuntenhausen / DE
	[2013/29]
Representative(s)	dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB Deichmannhaus am Dom Bahnhofsvorplatz 1 50667 Köln / DE
	[N/P]
Former [2015/47]	Von Kreisler Selting Werner - Partnerschaft von Patentanwälten und Rechtsanwälten mbB Deichmannhaus am Dom Bahnhofsvorplatz 1 50667 Köln / DE
Former [2013/29]	von Kreisler Selting Werner Deichmannhaus am Dom Bahnhofsvorplatz 1 50667 Köln / DE
Application number, filing date	11769801.9	12.09.2011
	[2015/47]
	WO2011EP65735
Priority number, date	EP20100176224	10.09.2010 Original published format: EP 10176224
	[2013/29]
Filing language	DE
Procedural language	DE
Publication	Type:	A1 Application with search report
	No.:	WO2012032185
	Date:	15.03.2012
	Language:	DE
	[2012/11]
	Type:	A1 Application with search report
	No.:	EP2614045
	Date:	17.07.2013
	Language:	DE
	The application published by WIPO in one of the EPO official languages on 15.03.2012 takes the place of the publication of the European patent application.
	[2013/29]
	Type:	B1 Patent specification
	No.:	EP2614045
	Date:	18.11.2015
	Language:	DE
	[2015/47]
Search report(s)	International search report - published on:	EP	15.03.2012
Classification	IPC:	C07C227/42, C07C229/64, A61K31/606, A61P29/00	[2013/29]
	CPC:	C07C227/42 (EP,KR,US); A61K31/606 (EP,KR,US); A61P1/04 (EP); A61P29/00 (EP); A61P31/06 (EP); C07C229/64 (KR,US)
	C-Set:	C07C227/42, C07C229/64 (EP,US)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/29]
Extension states	BA	Not yet paid
	ME	Not yet paid
Title	German:	VERFAHREN ZUR HERSTELLUNG KRISTALLINER 5-AMINOSALICYLSÄURE	[2013/29]
	English:	METHOD FOR PRODUCING CRYSTALLINE 5-AMINOSALICYLIC ACID	[2013/29]
	French:	PROCÉDÉ DE PRODUCTION D'ACIDE 5-AMINOSALICYLIQUE CRISTALLIN	[2013/29]
Entry into regional phase	05.04.2013	National basic fee paid
	05.04.2013	Designation fee(s) paid
	05.04.2013	Examination fee paid
Examination procedure	05.04.2013	Examination requested [2013/29]
	11.07.2013	Amendment by applicant (claims and/or description)
	18.07.2014	Despatch of a communication from the examining division (Time limit: M04)
	25.07.2014	Reply to a communication from the examining division
	07.10.2014	Observations by third parties
	08.10.2014	Communication of intention to grant the patent
	23.10.2014	Despatch of a communication from the examining division (Time limit: M04)
	18.02.2015	Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
	20.02.2015	Reply to a communication from the examining division
	06.05.2015	Communication of intention to grant the patent
	03.09.2015	Fee for grant paid
	03.09.2015	Fee for publishing/printing paid
	03.09.2015	Receipt of the translation of the claim(s)
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 18.07.2014
Opposition(s)	Opponent(s)	01 16.08.2016 24.08.2016 ADMISSIBLE Cambrex Karlskoga AB 691 85 Karlskoga / SE Opponent's representative Potter Clarkson Chapel Quarter Mount Street Nottingham NG1 6HQ / GB
		[N/P]
	Former [2016/39]
	Opponent(s)	01 16.08.2016 24.08.2016 ADMISSIBLE Cambrex Karlskoga AB 691 85 Karlskoga / SE Opponent's representative Potter Clarkson LLP The Belgrave Centre Talbot Street Nottingham NG1 5GG / GB
	26.09.2016	Invitation to proprietor to file observations on the notice of opposition
	22.12.2016	Despatch of communication that the patent will be revoked
	01.01.2017	Legal effect of revocation of patent [2017/19]
Fees paid	Renewal fee
	26.09.2013	Renewal fee patent year 03
	25.09.2014	Renewal fee patent year 04
	28.09.2015	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	AL	18.11.2015
	BG	18.11.2015
	CH	18.11.2015
	CY	18.11.2015
	CZ	18.11.2015
	EE	18.11.2015
	FI	18.11.2015
	HR	18.11.2015
	LI	18.11.2015
	LT	18.11.2015
	LV	18.11.2015
	MC	18.11.2015
	MT	18.11.2015
	NL	18.11.2015
	PL	18.11.2015
	RO	18.11.2015
	RS	18.11.2015
	SI	18.11.2015
	SK	18.11.2015
	SM	18.11.2015
	NO	18.02.2016
	GR	19.02.2016
	IS	18.03.2016
	PT	18.03.2016
	BE	30.09.2016
	[2020/21]
Former [2019/38]	AL	18.11.2015
	BG	18.11.2015
	CH	18.11.2015
	CZ	18.11.2015
	EE	18.11.2015
	FI	18.11.2015
	HR	18.11.2015
	LI	18.11.2015
	LT	18.11.2015
	LV	18.11.2015
	MC	18.11.2015
	MT	18.11.2015
	NL	18.11.2015
	PL	18.11.2015
	RO	18.11.2015
	RS	18.11.2015
	SI	18.11.2015
	SK	18.11.2015
	SM	18.11.2015
	NO	18.02.2016
	GR	19.02.2016
	IS	18.03.2016
	PT	18.03.2016
	BE	30.09.2016
Former [2018/46]	AL	18.11.2015
	CH	18.11.2015
	CZ	18.11.2015
	EE	18.11.2015
	FI	18.11.2015
	HR	18.11.2015
	LI	18.11.2015
	LT	18.11.2015
	LV	18.11.2015
	MC	18.11.2015
	MT	18.11.2015
	NL	18.11.2015
	PL	18.11.2015
	RO	18.11.2015
	RS	18.11.2015
	SI	18.11.2015
	SK	18.11.2015
	SM	18.11.2015
	NO	18.02.2016
	GR	19.02.2016
	IS	18.03.2016
	PT	18.03.2016
	BE	30.09.2016
Former [2018/34]	CH	18.11.2015
	CZ	18.11.2015
	EE	18.11.2015
	FI	18.11.2015
	HR	18.11.2015
	LI	18.11.2015
	LT	18.11.2015
	LV	18.11.2015
	MC	18.11.2015
	MT	18.11.2015
	NL	18.11.2015
	PL	18.11.2015
	RO	18.11.2015
	RS	18.11.2015
	SI	18.11.2015
	SK	18.11.2015
	SM	18.11.2015
	NO	18.02.2016
	GR	19.02.2016
	IS	18.03.2016
	PT	18.03.2016
	BE	30.09.2016
Former [2017/43]	CH	18.11.2015
	CZ	18.11.2015
	EE	18.11.2015
	FI	18.11.2015
	HR	18.11.2015
	LI	18.11.2015
	LT	18.11.2015
	LV	18.11.2015
	MC	18.11.2015
	NL	18.11.2015
	PL	18.11.2015
	RO	18.11.2015
	RS	18.11.2015
	SI	18.11.2015
	SK	18.11.2015
	SM	18.11.2015
	NO	18.02.2016
	GR	19.02.2016
	IS	18.03.2016
	PT	18.03.2016
	BE	30.09.2016
Former [2017/31]	CZ	18.11.2015
	EE	18.11.2015
	FI	18.11.2015
	HR	18.11.2015
	LT	18.11.2015
	LV	18.11.2015
	MC	18.11.2015
	NL	18.11.2015
	PL	18.11.2015
	RO	18.11.2015
	RS	18.11.2015
	SI	18.11.2015
	SK	18.11.2015
	SM	18.11.2015
	NO	18.02.2016
	GR	19.02.2016
	IS	18.03.2016
	PT	18.03.2016
	BE	30.09.2016
Former [2017/12]	CZ	18.11.2015
	EE	18.11.2015
	FI	18.11.2015
	HR	18.11.2015
	LT	18.11.2015
	LV	18.11.2015
	NL	18.11.2015
	PL	18.11.2015
	RO	18.11.2015
	RS	18.11.2015
	SI	18.11.2015
	SK	18.11.2015
	SM	18.11.2015
	NO	18.02.2016
	GR	19.02.2016
	IS	18.03.2016
	PT	18.03.2016
	BE	30.09.2016
Former [2016/49]	CZ	18.11.2015
	EE	18.11.2015
	FI	18.11.2015
	HR	18.11.2015
	LT	18.11.2015
	LV	18.11.2015
	NL	18.11.2015
	PL	18.11.2015
	RO	18.11.2015
	RS	18.11.2015
	SI	18.11.2015
	SK	18.11.2015
	SM	18.11.2015
	NO	18.02.2016
	GR	19.02.2016
	IS	18.03.2016
	PT	18.03.2016
Former [2016/38]	CZ	18.11.2015
	EE	18.11.2015
	FI	18.11.2015
	HR	18.11.2015
	LT	18.11.2015
	LV	18.11.2015
	NL	18.11.2015
	PL	18.11.2015
	RO	18.11.2015
	RS	18.11.2015
	SK	18.11.2015
	SM	18.11.2015
	NO	18.02.2016
	GR	19.02.2016
	IS	18.03.2016
	PT	18.03.2016
Former [2016/36]	CZ	18.11.2015
	EE	18.11.2015
	FI	18.11.2015
	HR	18.11.2015
	LT	18.11.2015
	LV	18.11.2015
	NL	18.11.2015
	PL	18.11.2015
	RO	18.11.2015
	RS	18.11.2015
	SK	18.11.2015
	NO	18.02.2016
	GR	19.02.2016
	IS	18.03.2016
	PT	18.03.2016
Former [2016/34]	CZ	18.11.2015
	FI	18.11.2015
	HR	18.11.2015
	LT	18.11.2015
	LV	18.11.2015
	NL	18.11.2015
	PL	18.11.2015
	RS	18.11.2015
	NO	18.02.2016
	GR	19.02.2016
	IS	18.03.2016
	PT	18.03.2016
Former [2016/25]	FI	18.11.2015
	HR	18.11.2015
	LT	18.11.2015
	LV	18.11.2015
	NL	18.11.2015
	PL	18.11.2015
	RS	18.11.2015
	NO	18.02.2016
	GR	19.02.2016
	IS	18.03.2016
	PT	18.03.2016
Former [2016/24]	FI	18.11.2015
	HR	18.11.2015
	LT	18.11.2015
	NL	18.11.2015
	PL	18.11.2015
	RS	18.11.2015
	NO	18.02.2016
	GR	19.02.2016
	IS	18.03.2016
	PT	18.03.2016
Former [2016/23]	HR	18.11.2015
	LT	18.11.2015
	NL	18.11.2015
	RS	18.11.2015
	NO	18.02.2016
	IS	18.03.2016
Former [2016/22]	LT	18.11.2015
	NL	18.11.2015
	NO	18.02.2016
	IS	18.03.2016
Former [2016/21]	LT	18.11.2015
	NO	18.02.2016
Former [2016/20]	LT	18.11.2015
Cited in	International search	[YD]WO0196280 (BFGOODRICH DIAMALT GMBH [DE], et al) [YD] 3-7 * page 1 - page 2; example 1 *;
		[A]WO2004093884 (FERRING BV [NL], et al) [A] 1-11 * page 2, line 5 - line 7; claims 12,16 *;
		[Y]WO2008013416 (AMOREPACIFIC CORP [KR], et al) [Y] 3-7* claims 1-2,17 *;
		[Y]EP2172193 (CAPSULUTION NANOSCIENCE AG [DE]) [Y] 3-7 * paragraphs [0007] , [0012]; claims 1,8,12,17 *;
		[I] - HAGSTEN ET AL, "Identifying sources of batch to batch variation in processability", POWDER TECHNOLOGY, ELSEVIER SEQUOIA, LAUSANNE, CH, (20080318), vol. 183, no. 2, doi:DOI:10.1016/J.POWTEC.2007.07.042, ISSN 0032-5910, pages 213 - 219, XP022541018 [I] 1,2,8-11 * page 214; table 1 * DOI: http://dx.doi.org/10.1016/j.powtec.2007.07.042
	Examination	US2009264386
		- SIROLA I ET AL, "Effect of crystal size and shape on bulk density of pharmaceutical powders", JOURNAL OF CRYSTAL GROWTH, ELSEVIER, AMSTERDAM, NL, (19971101), vol. 181, no. 4, doi:10.1016/S0022-0248(97)00299-6, ISSN 0022-0248, pages 403 - 409, XP004099528 DOI: http://dx.doi.org/10.1016/S0022-0248(97)00299-6
	by applicant	WO0196280
		- USP, (20090501), vol. 1, pages 226 - 227
		- "Particle Size Analysis by Laser Light Diffraction", European Pharmacopeia, pages 5103 - 5107
	other	US2009264386
		- SIROLA I. ET AL, "EFFECT OF CRYSTAL SIZE AND SHAPE ON BULK DENSITY OF PHARMACEUTICAL POWDERS", JOURNAL OF CRYSTAL GROWTH, (199711), vol. 181, no. 4, doi:10.1016/S0022-0248(97)00299-6, pages 403 - 409, XP028792065 DOI: http://dx.doi.org/10.1016/S0022-0248(97)00299-6
	Opposition	US4657900
		EP0270815
		WO9216206
		- ?IROLA et al., "effect of crystal size and shape on bulk density of pharmaceutical powders", Journal of Crystal Growth, (19970000), pages 403 - 409, XP055300864
		- BURDEN, D. W., Guide to the Homogenization of Biological Samples, (20080000), XP055145268
		- Formulation and Analytical Development for Low-dose Oral Drug Products, (20090000), pages 205 - 263
		- IVAN LEE et al., "Rotor-stator milling of APIs - empirical scale-up parameters and theoretical relationships between the morphology and breakage of crystals", American Pharmaceutical Review, (20040000), vol. 7, no. 5, pages 120 - 123 and 128, XP055300878

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p